Group 1 - The company has received a total of government subsidies amounting to RMB 28.85 million, which includes RMB 14.48 million related to income and RMB 14.37 million related to assets [1] - The income-related subsidies represent 19.55% of the company's audited net profit attributable to shareholders for the most recent fiscal year, while the asset-related subsidies account for 0.18% of the audited net assets [1] - The income-related government subsidies will be recognized as other income, with an expected impact of RMB 12.43 million on the 2025 profit and loss statement [1] Group 2 - The asset-related government subsidies will be recognized as deferred income, which will be amortized into the profit and loss statement over the estimated useful life of the related assets [1] - The specific accounting treatment and its impact on the company's annual profit will be confirmed after the annual audit by the accountant [1]
昭衍新药: 昭衍新药关于获得政府补助的公告